Did Mr. Buffett Really Want the NYSE Euronext (NYX)?

Page 1 of 2

Warren BuffettMedia outlets recently reported that Berkshire Hathaway made a bid for NYSE Euronext (NYSE:NYX) last year.  The owner of the iconic New York Stock Exchange ended up being acquired by IntercontinentalExchange Inc (NYSE:ICE) in December 2012 for roughly $8.2 billion.  The acquisition is the latest in a string of purchases for Intercontinental, as it seeks to increase market share against rival CME Group Inc (NASDAQ:CME), the owner of various exchanges including the Chicago Mercantile Exchange and Chicago Board of Trade.  So, should investors be in this sector too?

Intercontinental’s primary motivation for a merger was control of NYSE Euronext’s Liffe derivatives unit, which makes markets in a variety of equity and commodity derivative securities.  Despite owning the New York Stock Exchange, American Stock Exchange, and some European exchanges, NYSE Euronext’s stock listing business has had limited revenue and profit growth recently, due to the rise of alternative trading platforms.  In FY2011, the company reported that it only cleared 35% of all trades in NYSE-listed companies.

Meanwhile, the overall derivatives business has continued to grow, despite its significant role in the financial crisis.  In FY2011, NYSE Euronext’s derivatives unit posted revenue growth of 4.3% and accounted for over half of the company’s operating profit.  Its technology services unit has also been doing well, with revenues up 175% over the past four fiscal years, as more trading firms require improved trading technology and compliance services.

In FY2012, NYSE Euronext’s business has come under pressure, with volume declines in its stock listing and derivatives units.  For the first nine months of the year, it reported decreases in revenues and operating profit of 18.8% and 29.4%, respectively, versus the prior-year period.  While its stock listing business had flat revenues, NYSE Euronext’s derivatives segment was hurt by reduced market volatility and a reduction in derivatives trading.  The Fed is your friend, unless part of your business is providing protection against the Fed and other central banks’ actions.

Despite lower derivative trading in most areas in 2012, Intercontinental benefited from its strong market-making operations in Brent crude and various other agriculture products that were under supply constraints during the period.  Brent crude contracts have become increasingly popular as a hedging or speculation tool for crude oil, compared to West Texas Intermediate crude contracts.  In addition, the company profited from a 19% increase in sales of market data to trading participants.

In the first nine months of FY2012, Intercontinental reported increases in revenues and operating income of 3.9% and 6.1%, respectively, versus the prior-year period.  It benefited from revenue increases in all of its business units, as well as improved profitability from its move to an all-electronic platform with the October 2012 closure of its last open-outcry trading pit.  With $570 million in operating cash flow during the period, Intercontinental is using its financial strength to buy additional market share through its acquisition of NYSE Euronext.

In contrast, CME Group has had a down year, with lower trading volumes across the board, except in its agricultural products category.  For the first nine months of FY2012, the company reported decreases in revenues and operating income of 11.4% and 19.3%, respectively, compared to the prior-year period.  CME’s operating margin was hurt by a 26% decrease in trading volumes, as well as higher personnel and benefits costs.  However, the company continues to generate significant operating cash flow and is returning excess funds to shareholders.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!